cardio:beta_blockers:start
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| cardio:beta_blockers:start [2026/02/12 23:31] – [Clinical Pearls] andrew2393cns | cardio:beta_blockers:start [2026/02/12 23:47] (current) – [Mechanism of Action] andrew2393cns | ||
|---|---|---|---|
| Line 39: | Line 39: | ||
| • Some provide additional vasodilation (α1 or NO-mediated) | • Some provide additional vasodilation (α1 or NO-mediated) | ||
| - | Reference: [[autonomics: | + | Reference: [[autonomics: |
| -------------------------------------------------------------------- | -------------------------------------------------------------------- | ||
| Line 109: | Line 109: | ||
| -------------------------------------------------------------------- | -------------------------------------------------------------------- | ||
| + | ===== Beta-Blocker Comparison Table ===== | ||
| + | |||
| + | ^ Drug ^ Generation ^ Beta-1 Selective ^ Alpha-1 / Vasodilation ^ Lipophilic vs Hydrophilic ^ HFrEF Mortality Benefit ^ Common Uses ^ | ||
| + | |[[cardio: | ||
| + | | [[cardio: | ||
| + | |[[cardio: | ||
| + | |[[cardio: | ||
| + | |[[cardio: | ||
| + | |[[cardio: | ||
| + | |[[cardio: | ||
| + | |[[cardio: | ||
| + | |[[cardio: | ||
| ===== Intrinsic Sympathomimetic Activity (ISA) ===== | ===== Intrinsic Sympathomimetic Activity (ISA) ===== | ||
| Line 124: | Line 136: | ||
| • ★ [[cardio: | • ★ [[cardio: | ||
| - | • ★ [[cardio: | + | • ★ [[cardio: |
| • ★ [[cardio: | • ★ [[cardio: | ||
cardio/beta_blockers/start.1770939102.txt.gz · Last modified: by andrew2393cns
